The Latest Breaking News from Pfizer

ORIC Pharmaceuticals is a stock analyst price targets currently signal double-bagger potential in. See what the excitement around this firm is all about.

Thursday's trading session revealed 33 call options with unusually high activity and boasting expiration dates of 365 days or more. Three have emerged as promising long-term investments from this diverse pool of potential opportunities.

If Trump’s re-election is getting you down, these innovations in medicine and technology should cheer you up

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to spread

This pharmaceutical giant's Q3 numbers came in ahead of Street estimates.

Despite Pfizer’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

The Google parent is one of several mega caps reporting earnings this week, with results due out after Tuesday's close.

Pfizer stock is down Tuesday even after the drugmaker reported higher-than-expected Q3 earnings and raised its full-year outlook.

Myeloma affects 24,000 people a year in the UK

December S&P 500 E-Mini futures (ESZ24) are up +0.06%, and December Nasdaq 100 E-Mini futures (NQZ24) are up +0.08% this morning as market participants geared up for the latest reading on U.S. job openings while also awaiting a deluge of corporate earnings reports from heavyweight names.

Analysts say gold is benefited from safe-haven demand amid persistent geopolitical tensions, expectations of monetary policy easing, and mounting uncertainty surrounding the US presidential election.